Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1111 AL 1125

Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim

Weinreb O, Mandel S, Bar-Am O, Amit T.

J Neural Transm (Vienna). 2011 Mar;118(3):479-92. doi: 10.1007/s00702-011-0597-6. Epub 2011 Mar 1.

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases

Kawamata J, Shimohama S.

J Alzheimers Dis. 2011;24 Suppl 2:95-109. doi: 10.3233/JAD-2011-110173.

Metal ions, Alzheimer's disease and chelation therapy

Budimir A.

Acta Pharm. 2011 Mar;61(1):1-14. doi: 10.2478/v10007-011-0006-6.

Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?

Sutherland GT, Siebert GA, Kril JJ, Mellick GD.

J Alzheimers Dis. 2011;25(3):395-415. doi: 10.3233/JAD-2011-110026.

Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease

Shim B, Landerman LR, Davis LL.

J Adv Nurs. 2011 Aug;67(8):1729-38. doi: 10.1111/j.1365-2648.2011.05618.x. Epub 2011 Apr 4.

Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis

Luchetti S, Huitinga I, Swaab DF.

Neuroscience. 2011 Sep 15;191:6-21. doi: 10.1016/j.neuroscience.2011.04.010. Epub 2011 Apr 15.

DNA methylation in neurodegenerative disorders: a missing link between genome and environment?

Iraola-Guzmán S, Estivill X, Rabionet R.

Clin Genet. 2011 Jul;80(1):1-14. doi: 10.1111/j.1399-0004.2011.01673.x. Epub 2011 May 4.

Alzheimer's disease

Selkoe DJ.

Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7):a004457. doi: 10.1101/cshperspect.a004457.

Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

Nakamura T, Lipton SA.

Cell Death Differ. 2011 Sep;18(9):1478-86. doi: 10.1038/cdd.2011.65. Epub 2011 May 20.

Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study)

Kulisevsky J, Pagonabarraga J, Llebaria G, Hernández B, Arranz J; Grupo de Investigadores del estudio DIFUSION.

Neurologia. 2011 Oct;26(8):461-7. doi: 10.1016/j.nrl.2011.03.013. Epub 2011 May 28.

Neuroregeneration in neurodegenerative disorders

Enciu AM, Nicolescu MI, Manole CG, Mureşanu DF, Popescu LM, Popescu BO.

BMC Neurol. 2011 Jun 23;11:75. doi: 10.1186/1471-2377-11-75.

Neuropathology underlying clinical variability in patients with synucleinopathies

Halliday GM, Holton JL, Revesz T, Dickson DW.

Acta Neuropathol. 2011 Aug;122(2):187-204. doi: 10.1007/s00401-011-0852-9. Epub 2011 Jul 1.

Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence?

LaRoia H, Louis ED.

Neuroepidemiology. 2011;37(1):1-10. doi: 10.1159/000328866. Epub 2011 Jul 13.

Altered microstructure in corticospinal tract in idiopathic normal pressure hydrocephalus: comparison with Alzheimer disease and Parkinson disease with dementia

Hattori T, Yuasa T, Aoki S, Sato R, Sawaura H, Mori T, Mizusawa H.

AJNR Am J Neuroradiol. 2011 Oct;32(9):1681-7. doi: 10.3174/ajnr.A2570. Epub 2011 Aug 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias